| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| KLT-1101 | KLT-1101 | Phase 2 Clinical | Kang Litai Pharmaceutical Co Ltd | Solid tumours; Leukopenia; Thrombocytopenia; Melanoma; Sarcoma, Kaposi | 상세 |
| Edodekin alfa | RO 247472; YM 01C | Phase 2 Clinical | Wistar Institute, Valeant, F. Hoffmann-La Roche Ltd | Breast Neoplasms; Leishmaniasis; Bacterial Infections; Melanoma; Sarcoma, Kaposi; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma; Carcinoma, Squamous Cell; Hepatitis C; Asthma; Solid tumours; Hepatitis B; Graft vs Host Disease; Carcinoma, Ovarian Epithelial; Neoplasms; Malaria; Carcinoma, Renal Cell; Abdominal Neoplasms; Squamous Cell Carcinoma of Head and Neck; HIV Infections | 상세 |
| GEN-1 | phIL-12-005/PPC; GEN-1; EGEN-001; IMNN-001 | Phase 2 Clinical | Expression Genetics | Cystadenocarcinoma; Ovarian Neoplasms; Cystadenocarcinoma, Serous; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Endometrioid | 상세 |
| RTX-224 | RTX-224 | Phase 2 Clinical | Rubius Therapeutics Inc | Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung | 상세 |
| SON-1010 | SON-1010 | Phase 2 Clinical | Sonnet Biotherapeutics Inc | Ovarian Neoplasms; Solid tumours | 상세 |
| ASP-9801 | ASP-9801 | Phase 1 Clinical | Astellas Pharma Inc | Solid tumours; Neoplasms; Neoplasm Metastasis | 상세 |
| ANK-101 | ANK101; ANK-101 | Phase 1 Clinical | Ankyra Therapeutics Inc | Solid tumours; Soft Tissue Injuries; Skin Neoplasms; Carcinoma, Non-Small-Cell Lung | 상세 |
| CLN-617 | CLN-617 | Phase 1 Clinical | Cullinan Oncology | Solid tumours | 상세 |
| KB-707 | KB-707; KB707 | Phase 1 Clinical | Krystal Biotech Inc | Solid tumours; Skin Melanoma; Carcinoma, Basal Cell; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Neoplasms; Sarcoma; Osteosarcoma; Colorectal Neoplasms; Carcinoma, Squamous Cell; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular | 상세 |
| Encapsulated pancreatic cancer vaccine(Therapyx) | PCX-12 | Phase 1 Clinical | TherapyX Inc | Pancreatic Neoplasms | 상세 |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 가장 빠른 브랜드 이름 | 가장 빠른 승인 국가 | 가장 빠른 적응증 | 가장 빠른 승인 회사 | 가장 빠른 승인 날짜 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ustekinumab biosimilar (Samsung Bioepis) | SB-17; SB17 | Approved | Samsung Bioepis Co Ltd | Pyzchiva | EU | Crohn Disease; Colitis, Ulcerative | Samsung Bioepis Nl Bv | 2024-04-19 | Gastrointestinal Diseases; Skin Diseases; Psoriasis; Arthritis, Psoriatic; Rheumatic Diseases; Colitis, Ulcerative; Inflammation; Crohn Disease; Plaque psoriasis | 상세 |

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호



